Comprehensive Registry of Left Main Coronary Artery Percutaneous Coronary Intervention Outcomes at Istanbul Medipol University Hospital
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 3,620
- 试验地点
- 1
- 主要终点
- Incidence of Major Adverse Cardiac Events (MACE) within One Year Following Left Main Coronary Artery PCI
研究概览
简要总结
This hospital-based registry study at Istanbul Medipol University Hospital focuses on documenting and analyzing the clinical and demographic characteristics, procedural-related aspects, and both short and long-term outcomes of patients undergoing left main coronary artery percutaneous coronary intervention (PCI). The study aims to identify predictors for adverse clinical outcomes in patients treated for left main coronary artery disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients undergoing any PCI procedure(s) in given timeframe will be included in this registry
排除标准
- •Patients with no informed consent
结局指标
主要结局
Incidence of Major Adverse Cardiac Events (MACE) within One Year Following Left Main Coronary Artery PCI
时间窗: up to 1 month, 3 months, 1 year
The primary outcome measure will be the incidence of major adverse cardiac events (MACE) within one year post-procedure in patients undergoing left main coronary artery PCI. MACE is defined as a composite of clinically significant endpoints including all-cause mortality, non-fatal myocardial infarction, non-fatal stroke, and any revascularization procedures required after the initial PCI.
次要结局
- Procedure-Related Complications Within 30 Days of PCI(1 month)
- Rate of stent thrombosis(1 month, 3 months, 1 year)
- Ischemia-Driven Target Vessel Revascularization (ID-TVR) Ischemia-Driven Target Vessel Revascularization (ID-TVR)(1 year)
- Health-Related Quality of Life (HRQoL) Scores One Year After PCI(1 year)
研究者
Ozgur Ulas Ozcan
Prof Dr Ozgur Ulas Ozcan
Medipol University